TNF and psoriasis: Patients with psoriasis, have shown a significantly increased risk of AD when compared with healthy controls [37, 38] whilst therapeutics for psoriasis are being investigated for their possible impact on AD, with TNF blocking agents associated with lower risk of AD for [39].